This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Topiramate (2013-09-13)
- Starting date:
- September 13, 2013
- Posting date:
- September 23, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-35861
Recalled Products
A. Topiramate, 25.0 mg
B. Topiramate, 100.0 mg
Reason
The indicated lots may not meet the registered limit for sulfate toward the end of shelf life.
Depth of distribution
Wholesalers in the province of Quebec.
Affected products
Topiramate, 25.0 mg
DIN, NPN, DIN-HIM
DIN 02389460
Dosage form
Tablet
Strength
- Topiramate, 25.0 mg
Lot or serial number
- KE4385
Companies
- Recalling Firm
-
Sivem Pharmaceuticals ULC
4705 Dobrin Street
Ville Saint-Laurent
H4R 2P7
Quebec
CANADA
- Marketing Authorization Holder
-
Sivem Pharmaceuticals ULC
4705 Dobrin Street
Ville Saint-Laurent
H4R 2P7
Quebec
CANADA
Topiramate, 100.0 mg
DIN, NPN, DIN-HIM
DIN 02389487
Dosage form
Tablet
Strength
- Topiramate, 100.0 mg
Lot or serial number
- KE4383
Companies
- Recalling Firm
-
Sivem Pharmaceuticals ULC
4705 Dobrin Street
Ville Saint-Laurent
H4R 2P7
Quebec
CANADA
- Marketing Authorization Holder
-
Sivem Pharmaceuticals ULC
4705 Dobrin Street
Ville Saint-Laurent
H4R 2P7
Quebec
CANADA